Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 1997

Olson S H, Finstad C L, Harlap S, Kurian L, Saigo P E, Barakat R R

Abstract excerpt

We studied 54 patients diagnosed with endometrial cancer between 1981 and 1994 following a diagnosis of breast cancer. We used a case-case analysis, comparing tumors with and without overexpression of the p53 gene product to evaluate the association of putative p53 mutations with tamoxifen use and other risk factors for endometrial cancer. Twenty-four % of the tumors showed strong positive staining for the p53...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genes, p53

Share to Immunohistochemistry

Share to Mutation

Share to Risk Factors

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9332764

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancer.PMID 9332764Read ↗

p53 protein overexpression in relation to risk factors for breast cancer.Semantic proximity Read ↗

Molecular basis of endometrial cancerSemantic proximity Read ↗

p53 overexpression as a prognostic indicator in endometrial carcinoma.Semantic proximity Read ↗

Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.Semantic proximity Read ↗

p53 overexpression and mutation in endometrial carcinoma: inverted relation with estrogen and progesterone receptor status.Semantic proximity Read ↗

p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review.Semantic proximity Read ↗

Endometrial carcinoma in tamoxifen-treated breast cancer patient: clinicopathological, immunohistochemical, and genetic analysis.Semantic proximity Read ↗

Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity.Semantic proximity Read ↗

Prognostic value of p53 and K-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison.Semantic proximity Read ↗

MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.Semantic proximity Read ↗

Mutations and amplification of oncogenes in endometrial cancer.Semantic proximity Read ↗

Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.